Analyst Says Sell Depomed As Challenging Opioid Environment Seen Persisting
August 08, 2017 at 13:17 PM EDT
Shares of Depomed are plunging after the company reported weaker than expected second quarter results and lowered its guidance.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.